TY - JOUR
T1 - Effects of the 5-HT1A receptor agonist tandospirone on ACTH-induced sleep disturbance in rats
AU - Tsutsui, Ryuki
AU - Shinomiya, Kazuaki
AU - Sendo, Toshiaki
AU - Kitamura, Yoshihisa
AU - Kamei, Chiaki
N1 - Publisher Copyright:
© 2015 The Pharmaceutical Society of Japan.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - The aim of this study was to compare the effect of the serotonin (5-HT)1A receptor agonist tandospirone versus that of the benzodiazepine hypnotic flunitrazepam in a rat model of long-term adrenocorticotropic hormone (ACTH)-induced sleep disturbance. Rats implanted with electrodes for recording electroencephalogram and electromyogram were injected with ACTH once daily at a dose of 100 μg/rat. Administration of ACTH for 10 d caused a significant increase in sleep latency, decrease in non-rapid eye movement (non-REM) sleep time, and increase in wake time. Tandospirone caused a significant decrease in sleep latency and increase in non-REM sleep time in rats treated with ACTH. The effect of tandospirone on sleep patterns was antagonized by the 5-HT1A receptor antagonist WAY-100635. In contrast, flunitrazepam had no significant effect on sleep parameters in ACTH-treated rats. These results clearly indicate that long-term administration of ACTH causes sleep disturbance, and stimulating the 5-HT1A receptor by tandospirone may be efficacious for improving sleep in cases in which benzodiazepine hypnotics are ineffective.
AB - The aim of this study was to compare the effect of the serotonin (5-HT)1A receptor agonist tandospirone versus that of the benzodiazepine hypnotic flunitrazepam in a rat model of long-term adrenocorticotropic hormone (ACTH)-induced sleep disturbance. Rats implanted with electrodes for recording electroencephalogram and electromyogram were injected with ACTH once daily at a dose of 100 μg/rat. Administration of ACTH for 10 d caused a significant increase in sleep latency, decrease in non-rapid eye movement (non-REM) sleep time, and increase in wake time. Tandospirone caused a significant decrease in sleep latency and increase in non-REM sleep time in rats treated with ACTH. The effect of tandospirone on sleep patterns was antagonized by the 5-HT1A receptor antagonist WAY-100635. In contrast, flunitrazepam had no significant effect on sleep parameters in ACTH-treated rats. These results clearly indicate that long-term administration of ACTH causes sleep disturbance, and stimulating the 5-HT1A receptor by tandospirone may be efficacious for improving sleep in cases in which benzodiazepine hypnotics are ineffective.
KW - Adrenocorticotropic hormone
KW - Gamma-aminobutyric acid
KW - Serotonin (5-HT) receptor
KW - Sleep disturbance
UR - http://www.scopus.com/inward/record.url?scp=84936764646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84936764646&partnerID=8YFLogxK
U2 - 10.1248/bpb.b14-00887
DO - 10.1248/bpb.b14-00887
M3 - Article
C2 - 26027828
AN - SCOPUS:84936764646
SN - 0918-6158
VL - 38
SP - 884
EP - 888
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 6
ER -